ALBIREO PHARMA INC (ALBO)
US01345P1066 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -131.15M | -34.03M | -107.63M | -62.72M | -46.11M | |||
| Depreciation Amortization | 429.00K | 274.00K | 190.00K | 130.00K | 50.00K | |||
| Change In Working Capital | -20.21M | -9.68M | -4.66M | -10.27M | 2.13M | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 20.00K | N/A | |||
| Other non cash items | 35.61M | -64.12M | 11.07M | 19.94M | 17.14M | |||
| OPERATING CASH FLOW | -115.32M | -107.56M | -101.03M | -52.92M | -26.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -960.00K | -465.00K | -80.00K | -540.00K | -60.00K | |||
| Other Investing Activity | N/A | 103.39M | N/A | 0.00 | 10.00K | |||
| INVESTING CASH FLOW | -960.00K | 102.92M | -80.00K | -540.00K | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 9.49M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 27.25M | 2.76M | 196.04M | 23.50M | 94.66M | |||
| Other Financing Activity | N/A | 0.00 | 14.75M | 0.00 | 44.53M | |||
| FINANCING CASH FLOW | 128.04M | 2.76M | 220.28M | 23.50M | 139.18M | |||
| Exchange Rate Effect | -1.89M | -1.29M | 260.00K | -2.09M | -1.68M | |||
| CHANGE IN CASH | 9.86M | -3.17M | 119.43M | -32.05M | 110.65M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -115.32M | -107.56M | -101.03M | -52.92M | -26.80M | |||
| Capital Expenditure | -960.00K | -465.00K | -80.00K | -540.00K | -60.00K | |||
| FREE CASH FLOW | -116.28M | -108.02M | -101.11M | -53.46M | -26.86M | |||
All data in USD